Combination chemotherapy with paclitaxel, ifoseamide, and nedaplatin in patients with urothelial cancer who had received prior cisplatin-based therapy: Advanced report

被引：0
|
作者：
不详
机构：
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2006年 / 5卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：291 / 291
页数：1
相关论文
共 50 条
  • [41] Venous thromboembolic events in patients with lung cancer treated with cisplatin-based versus carboplatin/nedaplatin-based chemotherapy
    Mitani, Akihisa
    Jo, Taisuke
    Yasunaga, Hideo
    Sakamoto, Yukiyo
    Hasegawa, Wakae
    Urushiyama, Hirokazu
    Yamauchi, Yasuhiro
    Matsui, Hiroki
    Fushimi, Kiyohide
    Nagase, Takahide
    ANTI-CANCER DRUGS, 2018, 29 (06) : 560 - 564
  • [42] Prognostic model for overall survival in patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy
    Galsky, Matt D.
    Krege, Susanne
    Lin, Chia-Chi
    Hahn, Noah M.
    Ecke, Thorsten
    Moshier, Erin L.
    Sonpavde, Guru
    Godbold, James H.
    Oh, William K.
    Bamias, Aristotelis
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [43] Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based Chemotherapy
    Apolo, Andrea B.
    Ostrovnaya, Irina
    Halabi, Susan
    Iasonos, Alexia
    Philips, George K.
    Rosenberg, Jonathan E.
    Riches, Jamie
    Small, Eric J.
    Milowsky, Matthew I.
    Bajorin, Dean F.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (07): : 499 - 503
  • [44] A phase II study of weekly paclitaxel in patients with advanced or recurrent esophageal cancer who had previously received docetaxel-containing chemotherapy
    Ando, T.
    Nakashima, K.
    Yoshita, H.
    Sakumura, M.
    Nomura, M.
    Muto, M.
    Fujii, H.
    Horie, Y.
    Takeda, H.
    Yoshii, T.
    Tahara, Y.
    Katada, C.
    Yoshimura, K.
    Ishikawa, H.
    Hosokawa, A.
    ANNALS OF ONCOLOGY, 2022, 33 : S288 - S288
  • [45] Paclitaxel and cisplatin combination chemotherapy for advanced gastric cancer failed to 5-fluorouracil-based chemotherapy
    Kim, Y.
    Kim, M.
    Lee, S. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [46] Significance of second progression-free survival in patients with advanced urothelial cancer who received platinum-based combination chemotherapy followed by pembrolizumab
    Sato, Ryo
    Inamoto, Teruo
    Matsushita, Yuto
    Takemura, Ayana
    Uchimoto, Taizo
    Sano, Asuka
    Tanaka, Hiroki
    Ishikawa, Gaku
    Watanabe, Kyohei
    Watanabe, Hiromitsu
    Tamura, Keita
    Motoyama, Daisuke
    Sugiyama, Takayuki
    Otsuka, Atsushi
    Harada, Ken-ichi
    Azuma, Haruhito
    Miyake, Hideaki
    INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (09) : 730 - 736
  • [47] Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy
    Jong Gwang Kim
    Baek-Yeol Ryoo
    Yeon Hee Park
    Bong-Seog Kim
    Tae-You Kim
    Young-Hyuck Im
    Yoon-Koo Kang
    Cancer Chemotherapy and Pharmacology, 2008, 61 : 301 - 307
  • [48] Concurrent, cisplatin-based chemotherapy with accelerated radiotherapy for advanced head and neck cancer patients
    Skladowski, K. A., Sr.
    Rutkowski, T.
    Wygoda, A.
    Golen, M.
    Pilecki, B.
    Przeorek, W.
    Lukaszczyk-Widel, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [49] Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy
    Kim, Jong Gwang
    Ryoo, Baek-Yeol
    Park, Yeon Hee
    Kim, Bong-Seog
    Kim, Tae-You
    Im, Young-Hyuck
    Kang, Yoon-Koo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (02) : 301 - 307
  • [50] Combination chemotherapy with 5-fluorouracil, cisplatin and paclitaxel for pretreated patients with advanced gastric cancer
    Yamaguchi, Kentaro
    Nakagawa, Satoru
    Yabusaki, Hiroshi
    Nashimoto, Atsushi
    ANTICANCER RESEARCH, 2007, 27 (5B) : 3535 - 3539
12345